2,019
Views
0
CrossRef citations to date
0
Altmetric
Cancer Biology

Systemic analysis the expression, prognostic, and immune infiltrates significance of MS4A family in lung cancer

ORCID Icon, , , , & ORCID Icon
Pages 134-146 | Received 25 Jul 2021, Accepted 31 Dec 2021, Published online: 17 Jan 2022

References

  • Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, Bonaventure A, Valkov M, Johnson CJ, Estève J, et al. 2018. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 391:1023–1075.
  • Beer DG, Kardia SLR, Huang C-C, Giordano TJ, Levin AM, Misek DE, Lin L, Chen G, Gharib TG, Thomas DG, et al. 2002. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med. 8(8):816–824.
  • Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R, Gillette M, et al. 2001. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A. 98(24):13790–13795.
  • Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf A, Angell H, Fredriksen T, Lafontaine L, Berger A, et al. 2013. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 39(4):782–795.
  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A, et al. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68(6):394–424.
  • Bremnes RM, Busund L-T, Kilvær TL, Andersen S, Richardsen E, Paulsen EE, Hald S, Khanehkenari MR, Cooper WA, Kao SC, Dønnem T. 2016. The role of tumor-infiltrating lymphocytes in development, progression, and prognosis of non-small cell lung cancer. J Thorac Oncol. 11(6):789–800.
  • Chiba S, Ikushima H, Ueki H, Yanai H, Kimura Y, Hangai S, Nishio J, Negishi H, Tamura T, Saijo S, et al. 2014. Recognition of tumor cells by Dectin-1 orchestrates innate immune cells for anti-tumor responses. Elife. 3:e04177.
  • Cruse G, Beaven MA, Ashmole I, Bradding P, Gilfillan AM, Metcalfe DD. 2013. A truncated splice-variant of the FcϵRIβ receptor subunit Is critical for microtubule formation and degranulation in mast cells. Immunity. 38(5):906–917.
  • Donato J, Ko J, Kutok J, Cheng T, Shirakawa T, Mao X-Q, Beach D, Scadden DT, Sayegh MH, Adra CN. 2002. Human HTm4 is a hematopoietic cell cycle regulator. J Clin Invest. 109:51–58.
  • Donnadieu E, Jouvin M-H, Rana S, Moffatt MF, Mockford EH, Cookson WO, Kinet J-P. 2003. Competing functions encoded in the allergy-associated FcεRIβ gene. Immunity. 18(5):665–674.
  • Drew J, Farquharson A, Mayer C, Vase HF, Coates PJ, Steele RJ, Carey FA, Ashktorab H. 2014. Predictive gene signatures: molecular markers distinguishing colon adenomatous polyp and carcinoma. PloS one. 9:e113071.
  • Gao J, Aksoy BA, Dogrusoz U, et al. 2013. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 6(269):pl1.
  • Garber ME, Troyanskaya OG, Schluens K, Petersen S, Thaesler Z, Pacyna-Gengelbach M, van de Rijn M, Rosen GD, Perou CM, Whyte RI, et al. 2001. Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci U S A. 98(24):13784–13789.
  • Hirsch FR, Scagliotti GV, Mulshine JL, et al. 2017. Lung cancer: current therapies and new targeted treatments. The Lancet. 389(10066):299–311.
  • Hou J, Aerts J, den Hamer B, et al. 2010. Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS One. 5(4):e10312–e10312.
  • Huang DW, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 4(1):44–57.
  • Hulett MD, Pagler E, Hornby JR, Hogarth PM, Eyre HJ, Baker E, Crawford J, Sutherland GR, Ohms SJ, Parish CR. 2001. Isolation, tissue distribution, and chromosomal localization of a novel testis-specific human four-transmembrane gene related to CD20 and FcεRI-β. Biochem Biophys Res Commun. 280(1):374–379.
  • Koslowski M, Sahin U, Dhaene K, Huber C, Türeci Ö. 2008. MS4A12 is a colon-selective store-operated calcium channel promoting malignant cell processes. Cancer Res. 68(9):3458–3466.
  • Kutok JL, Yang X, Folkerth R, Adra CN. 2011. Characterization of the expression of HTm4 (MS4A3), a cell cycle regulator, in human peripheral blood cells and normal and malignant tissues. J Cell Mol Med. 15(1):86–93.
  • Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B, Liu XS. 2017. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 77(21):e108–e110.
  • Liu X, Wu S, Yang Y, Zhao M, Zhu G, Hou Z. 2017. The prognostic landscape of tumor-infiltrating immune cell and immunomodulators in lung cancer. Biomed Pharmacother. 95:55–61.
  • Liu Y, Cao X. 2016. Immunosuppressive cells in tumor immune escape and metastasis. J Mol Med. 94(5):509–522.
  • Martiskainen H, Viswanathan J, Nykänen N-P, Kurki M, Helisalmi S, Natunen T, Sarajärvi T, Kurkinen KMA, Pursiheimo J-P, Rauramaa T, et al. 2015. Transcriptomics and mechanistic elucidation of Alzheimer’s disease risk genes in the brain and in vitro models. Neurobiol Aging. 36(2):1221.e15–1221.e28.
  • Mattiola I, Tomay F, De Pizzol M, Silva-Gomes R, Savino B, Gulic T, Doni A, Lonardi S, Astrid Boutet M, Nerviani A, et al. 2019. The macrophage tetraspan MS4A4A enhances dectin-1-dependent NK cell-mediated resistance to metastasis. Nat Immunol. 20:1012–1022.
  • Michel J, Schönhaar K, Schledzewski K, Gkaniatsou C, Sticht C, Kellert B, Lasitschka F, Géraud C, Goerdt S, Schmieder A. 2013. Identification of the novel differentiation marker MS4A8B and its murine homolog MS4A8A in colonic epithelial cells lost during neoplastic transformation in human colon. Cell Death Dis. 4(1):e469.
  • Molgora M, Esaulova E, Vermi W, Hou J, Chen Y, Luo J, Brioschi S, Bugatti M, Omodei AS, Ricci B, et al. 2020. TREM2 modulation remodels the tumor myeloid landscape enhancing anti-PD-1 immunotherapy. Cell. 182:886–900.e17.
  • Okami J, Shintani Y, Okumura M, Ito H, Ohtsuka T, Toyooka S, Mori T, Watanabe S-i, Date H, Yokoi K, et al. 2019. Demographics, safety and quality, and prognostic information in both the seventh and eighth editions of the TNM classification in 18,973 surgical cases of the Japanese joint committee of lung cancer registry database in 2010. J Thorac Oncol. 14(2):212–222.
  • Okayama H, Kohno T, Ishii Y, Shimada Y, Shiraishi K, Iwakawa R, Furuta K, Tsuta K, Shibata T, Yamamoto S, et al. 2012. Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas. Cancer Res. 72(1):100–111.
  • Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pander A, Chinnaiyan AM. 2004. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia. 6(1):1–6.
  • Selamat SA, Chung BS, Girard L, Zhang W, Zhang Y, Campan M, Siegmund KD, Koss MN, Hagen JA, Lam WL, et al. 2012. Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression. Genome Res. 22(7):1197–1211.
  • Stearman RS, Dwyer-Nield L, Zerbe L, Blaine SA, Chan Z, Bunn PA, Johnson GL, Hirsch FR, Merrick DT, Franklin WA, et al. 2005. Analysis of orthologous gene expression between human pulmonary Adenocarcinoma and a carcinogen-induced murine model. Am J Pathol. 167(6):1763–1775.
  • Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. 2021. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71(3):209–249.
  • Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, et al. 2019. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47(Database issue):D607–D613.
  • Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. 2017. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45(Web Server issue):W98–W102.
  • Thul PJ, Lindskog C. 2018. The human protein atlas: a spatial map of the human proteome. Protein Sci. 27(1):233–244.
  • van de Ven AAJM, Compeer EB, Bloem AC, van de Corput L, van Gijn M, van Montfrans JM, Boes M. 2012. Defective calcium signaling and disrupted CD20–B-cell receptor dissociation in patients with common variable immunodeficiency disorders. J Allergy Clin Immunol. 129(3):755–761.e7.
  • Vansteenkiste J, Crinò L, Dooms C, Douillard JY, Faivre-Finn C, Lim E, Rocco G, Senan S, Van Schil P, Veronesi G, et al. 2014. 2nd ESMO consensus conference on lung cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up. Ann Oncol. 25(8):1462–1474.
  • Ye L, Yao X-D, Wan F-N, Qu Y-Y, Liu Z-Y, Shen X-X, Li S, Liu X-J, Yue F, Wang N, et al. 2014. MS4A8B promotes cell proliferation in prostate cancer. Prostate. 74(9):911–922.
  • Zuccolo J, Deng L, Unruh T, Sanyal R, Bau JA, Storek J, Demetrick DJ, Luider JM, Auer-Grzesiak IA, Mansoor A, Deans JP. 2013. Expression of MS4A and TMEM176 genes in human B lymphocytes. Front Immunol. 4:195–195.